Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Clements

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
The Journal of Infectious Diseases|December 1, 1993
Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group NetworkR B Belshe, M L Clements, R Dolin, et al.
The Journal of Infectious Diseases|May 1, 1984
Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteersB R Murphy, M L Clements, H P Madore, et al.
Reviews of Infectious Diseases|May 1, 1989
Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young childrenA Z Kapikian, J Flores, Y Hoshino, et al.
Infection and Immunity|May 1, 1982
Evaluation of a phenotypic revertant of the A/Alaska/77-ts-1A2 reassortant virus in hamsters and in seronegative adult volunteers: further evidence that the temperature-sensitive phenotype is responsible for attenuation of ts-1A2 reassortant virusesM D Tolpin, M L Clements, M M Levine, et al.
The Journal of Infectious Diseases|March 1, 1993
Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challengeL F Fries, S B Dillon, J E Hildreth, et al.
The Journal of Infectious Diseases|August 11, 1992
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials NetworkB S Graham, R B Belshe, M L Clements, et al.
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1982
Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in manM M Levine, R E Black, C C Brinton, et al.
The New England Journal of Medicine|April 21, 1988
A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted feverA K Rao, M Schapira, M L Clements, et al.
The Journal of Infectious Diseases|November 1, 1983
Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted feverM L Clements, C L Wisseman, T E Woodward, et al.
Vaccine|August 7, 1999
A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvantT C Heineman, M L Clements-Mann, G A Poland, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
The Journal of Infectious Diseases|December 1, 1993
Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group NetworkR B Belshe, M L Clements, R Dolin, et al.
The Journal of Infectious Diseases|May 1, 1984
Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteersB R Murphy, M L Clements, H P Madore, et al.
Reviews of Infectious Diseases|May 1, 1989
Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young childrenA Z Kapikian, J Flores, Y Hoshino, et al.
Infection and Immunity|May 1, 1982
Evaluation of a phenotypic revertant of the A/Alaska/77-ts-1A2 reassortant virus in hamsters and in seronegative adult volunteers: further evidence that the temperature-sensitive phenotype is responsible for attenuation of ts-1A2 reassortant virusesM D Tolpin, M L Clements, M M Levine, et al.
The Journal of Infectious Diseases|March 1, 1993
Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challengeL F Fries, S B Dillon, J E Hildreth, et al.
The Journal of Infectious Diseases|August 11, 1992
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials NetworkB S Graham, R B Belshe, M L Clements, et al.
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1982
Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in manM M Levine, R E Black, C C Brinton, et al.
The New England Journal of Medicine|April 21, 1988
A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted feverA K Rao, M Schapira, M L Clements, et al.
The Journal of Infectious Diseases|November 1, 1983
Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted feverM L Clements, C L Wisseman, T E Woodward, et al.
Vaccine|August 7, 1999
A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvantT C Heineman, M L Clements-Mann, G A Poland, et al.
Pageof 13